Related Experiment Video
Updated: Jun 1, 2026

Preparation of Acute Spinal Cord Slices for Whole-cell Patch-clamp Recording in Substantia Gelatinosa Neurons
Published on: January 18, 2019
Regulation of spinal substance p release by intrathecal calcium channel blockade
Toshifumi Takasusuki1, Tony L Yaksh
1Department of Anesthesiology, School of Medicine, Dokkyo Medical University, Mibu, Tochigi, Japan.
Background:
The authors investigated the role of different voltage-sensitive calcium channels expressed at presynaptic afferent terminals in substance P release and on nociceptive behavior evoked by intraplantar formalin by examining the effects of intrathecally delivered N- (ziconotide), T- (mibefradil), and L-type voltage-sensitive calcium channel blockers (diltiazem and verapamil).
Methods:
Rats received intrathecal pretreatment with saline or doses of morphine, ziconotide, mibefradil, diltiazem, or verapamil. The effect of these injections upon flinching evoked by intraplantar formalin (5%, 50 microl) was quantified. To assess substance P release, the incidence of neurokinin-1 receptor internalization in the ipsilateral and contralateral lamina I was determined in immunofluorescent-stained tissues.
Results:
Intrathecal morphine (20 microg), ziconotide (0.3, 0.6, and 1 microg), mibefradil (100 microg, but not 50 microg), diltiazem (500 microg, but not 300 microg), and verapamil (200 microg, but not 50 and 100 microg) reduced paw flinching in phase 2 compared with vehicle control (P < 0.05), with no effect on phase 1. Ziconotide (0.3, 0.6, and 1 microg) and morphine (20 microg) significantly inhibited neurokinin-1 receptor internalization (P < 0.05), but mibefradil, diltiazem, and verapamil at the highest doses had no effect.
Conclusion:
These results emphasize the role in vivo of N-type but not T- and L-type voltage-sensitive calcium channel blockers in mediating the stimulus-evoked substance P release from small primary afferents and suggest that T- and L-type voltage-sensitive calcium channel blockers exert antihyperalgesic effects by an action on other populations of afferents or mechanisms involving postsynaptic excitability.
Insights
N-type calcium channel blockers reduced substance P release and nociception. T- and L-type blockers showed antihyperalgesic effects through different mechanisms, not involving substance P release.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Voltage-sensitive calcium channels (VSCCs) are crucial for neurotransmitter release at presynaptic terminals.
- Substance P release from small primary afferents mediates nociception.
- Different VSCC subtypes (N, T, L-type) may play distinct roles in pain pathways.
Purpose of the Study:
- To investigate the role of N-, T-, and L-type VSCCs in substance P release and formalin-induced nociceptive behavior.
- To determine the specific contribution of each VSCC subtype to pain modulation.
Main Methods:
- Rats received intrathecal administration of VSCC blockers (ziconotide, mibefradil, diltiazem, verapamil) or morphine.
- Nociceptive behavior (paw flinching) was quantified after intraplantar formalin injection.
- Substance P release was assessed by measuring neurokinin-1 receptor internalization in the spinal cord.
Main Results:
- N-type VSCC blocker (ziconotide) and morphine reduced paw flinching and neurokinin-1 receptor internalization.
- T- and L-type VSCC blockers (mibefradil, diltiazem, verapamil) reduced paw flinching but did not affect neurokinin-1 receptor internalization.
- Antihyperalgesic effects of T- and L-type blockers were observed in phase 2 of the formalin test.
Conclusions:
- N-type VSCCs are critical for stimulus-evoked substance P release from primary afferents in vivo.
- T- and L-type VSCC blockers likely exert antihyperalgesic effects via mechanisms independent of substance P release, possibly involving postsynaptic excitability.
Related Concept Videos
Local Anesthetics: Clinical Application as Spinal Anesthesia
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...

